Avanos Medical (AVNS) Q2 2024 Earnings
AVNS·Reported July 31, 2024·Before market open
Avanos Medical reported Q2 2024 revenue of $171.7M, beat analyst consensus of $170.7M by $1.0M. Diluted EPS came in at $0.34, beat the $0.29 consensus by $0.05.
Revenue
$171.7Mbeat by $1.0M
Consensus: $170.7MDiluted EPS
$0.34beat by $0.05
Consensus: $0.29
Financial Snapshot
Trailing eight quarters through Q2 2024
Q2 2024 Earnings FAQ
Common questions about Avanos Medical's Q2 2024 earnings report.
Avanos Medical (AVNS) reported Q2 2024 earnings on July 31, 2024 before market open.
Avanos Medical reported revenue of $171.7M and diluted EPS of $0.34 for Q2 2024.
Revenue beat the consensus estimate of $170.7M by $1.0M. EPS beat the consensus estimate of $0.29 by $0.05.
You can read the 10-Q periodic report (0001606498-24-000077) directly on SEC EDGAR. The filing index links above go to sec.gov.